A Study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Trial Participants
ConditionHealthy
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-65
SponsorBausch & Lomb Incorporated
About this trial
Single center, double-masked study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Subjects
Eligibility criteria
Qualifiers
Male or female ≥ 18 to ≤ 65 years of age.
In good health, as assessed at Screening by the Investigator from past medical history, physical examination (abbreviated), and laboratory tests.
Does not wear contact lenses, or is willing to refrain from wearing contact lenses for the duration of the study.
Disqualifiers
Women of childbearing potential or non-vasectomized males with partners of childbearing potential are not eligible unless they are using an effective method of contraception and agree to use an effective method of contraception until at least 30 days after study treatment.
Any medical condition (systemic or ophthalmic) that may, in the opinion of the Investigator, preclude the safe administration of IP, safe participation in this study, or confound the assessment of safety or efficacy.
Unwilling or unable to comply with the study protocol.
Trial design
Treatments tested in this trial
- BL1332 eye drops
- BL1332 Placebo eye drops
Treatment groups
28 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov